
Olmesartan Medoxomil (10mg)
Active composition
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Medical applications
Olmesafe 10 Tablet contains Olmesartan Medoxomil 10 mg, an angiotensin II receptor blocker (ARB) primarily indicated for the management of hypertension. By selectively inhibiting the binding of angiotensin II to the AT1 receptor subtype, Olmesartan Medoxomil promotes vasodilation, reduces aldosterone secretion, and decreases sodium and water retention, thereby effectively lowering blood pressure. Olmesafe 10 is prescribed to reduce the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure in hypertensive patients. The medication is generally well-tolerated, with common adverse effects including dizziness, headache, and fatigue. It is contraindicated in patients with hypersensitivity to Olmesartan or any component of the formulation, and caution is advised in individuals with impaired renal or hepatic function. Olmesartan should not be used during pregnancy due to the risk of fetal toxicity. Dosage adjustments may be necessary in patients with renal impairment. Olmesafe 10 can be administered once daily, with or without food, and adherence to prescribed therapy is essential for optimal blood pressure control. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment to ensure safety and efficacy.
Synthetic imidazole derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Olmesafe 10 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Olmesafe 10 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Olmesafe 10 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Olmesafe 10 Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment. Use of Olmesafe 10 Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Olmesafe 10 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Olmesafe 10 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Olmesafe 10 Tablet may be needed. Please consult your doctor. No dose adjustment is recommended in patients with mild liver disease.
Regular Checkup
0 reviews for Olmesafe 10 Tablet

Olmesartan Medoxomil (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Medical applications
Olmesafe 10 Tablet contains Olmesartan Medoxomil 10 mg, an angiotensin II receptor blocker (ARB) primarily indicated for the management of hypertension. By selectively inhibiting the binding of angiotensin II to the AT1 receptor subtype, Olmesartan Medoxomil promotes vasodilation, reduces aldosterone secretion, and decreases sodium and water retention, thereby effectively lowering blood pressure. Olmesafe 10 is prescribed to reduce the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure in hypertensive patients. The medication is generally well-tolerated, with common adverse effects including dizziness, headache, and fatigue. It is contraindicated in patients with hypersensitivity to Olmesartan or any component of the formulation, and caution is advised in individuals with impaired renal or hepatic function. Olmesartan should not be used during pregnancy due to the risk of fetal toxicity. Dosage adjustments may be necessary in patients with renal impairment. Olmesafe 10 can be administered once daily, with or without food, and adherence to prescribed therapy is essential for optimal blood pressure control. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment to ensure safety and efficacy.
Synthetic imidazole derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Olmesafe 10 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Olmesafe 10 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Olmesafe 10 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Olmesafe 10 Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment. Use of Olmesafe 10 Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Olmesafe 10 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Olmesafe 10 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Olmesafe 10 Tablet may be needed. Please consult your doctor. No dose adjustment is recommended in patients with mild liver disease.
Regular Checkup
0 reviews for Olmesafe 10 Tablet















